Dose Reduction Of Tocilizumab In Rheumatoid Arthritis Patients With Low Disease Activity Is Feasible

被引:0
|
作者
van Herwaarden, Noortje [1 ]
Herfkens-Hol, Susan [1 ]
van der Maas, Aatke [1 ]
van Den Bemt, Bart J. F. [1 ]
van Vollenhoven, Ronald F. [2 ]
Bijlsma, Johannes W. J. [3 ]
den Broeder, Alfons A. [1 ]
机构
[1] Sint Maartensklin, Nijmegen, Netherlands
[2] Karolinska Inst, Stockholm, Sweden
[3] Univ Med Ctr Utrecht, Utrecht, Netherlands
来源
ARTHRITIS AND RHEUMATISM | 2013年 / 65卷
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2327
引用
收藏
页码:S992 / S992
页数:1
相关论文
共 50 条
  • [41] Endothelial dysfunction in young rheumatoid arthritis patients with low disease activity
    Marchesi, S
    Vaudo, G
    Gerli, R
    Siepi, D
    Pirro, M
    Shoenfeld, Y
    Schillaci, E
    Mannarino, E
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 314 - 314
  • [42] Fatigue in rheumatoid arthritis patients is associated to subjective but not objective assessments of disease activity during treatment with tocilizumab
    Hammer, H. B.
    Agular, B.
    Terslev, L.
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2021, 50 : 23 - 24
  • [43] Tocilizumab Serum Trough Levels and Its Relationship with Disease Activity and Drug Dosage in Rheumatoid Arthritis Patients
    Ruiz-Esquide, Virginia
    Gonzalez-Navarro, Azucena
    Yaguee, Jordi
    Inciarte-Mundo, Jose
    Victoria Hernandez, M.
    Ramirez, Julio
    Cabrera-Villalba, Sonia
    Canete, Juan D.
    Sanmarti, Raimon
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1096 - S1096
  • [44] Subclinical atherosclerosis in young patients with rheumatoid arthritis and low disease activity
    Bocci, E. Bartoloni
    Marchesi, S.
    Delle Monache, F.
    Vaudo, G.
    Giordano, A.
    Alunni, F. Ragni
    Angrisani, C.
    Mannarino, E.
    Shoenfeld, Y.
    Gerli, R.
    [J]. REUMATISMO, 2005, 57 (01) : 16 - 21
  • [45] Comparison of the effects of baricitinib and tocilizumab on disease activity in patients with rheumatoid arthritis: a propensity score matching analysis
    Shuji Asai
    Nobunori Takahashi
    Tomonori Kobayakawa
    Atsushi Kaneko
    Tatsuo Watanabe
    Takefumi Kato
    Tsuyoshi Nishiume
    Hisato Ishikawa
    Yutaka Yoshioka
    Yasuhide Kanayama
    Tsuyoshi Watanabe
    Yuji Hirano
    Masahiro Hanabayashi
    Yuichiro Yabe
    Yutaka Yokota
    Mochihito Suzuki
    Kenya Terabe
    Naoki Ishiguro
    Shiro Imagama
    Toshihisa Kojima
    [J]. Clinical Rheumatology, 2021, 40 : 3143 - 3151
  • [46] Comparison of the effects of baricitinib and tocilizumab on disease activity in patients with rheumatoid arthritis: a propensity score matching analysis
    Asai, Shuji
    Takahashi, Nobunori
    Kobayakawa, Tomonori
    Kaneko, Atsushi
    Watanabe, Tatsuo
    Kato, Takefumi
    Nishiume, Tsuyoshi
    Ishikawa, Hisato
    Yoshioka, Yutaka
    Kanayama, Yasuhide
    Watanabe, Tsuyoshi
    Hirano, Yuji
    Hanabayashi, Masahiro
    Yabe, Yuichiro
    Yokota, Yutaka
    Suzuki, Mochihito
    Terabe, Kenya
    Ishiguro, Naoki
    Imagama, Shiro
    Kojima, Toshihisa
    [J]. CLINICAL RHEUMATOLOGY, 2021, 40 (08) : 3143 - 3151
  • [47] Successful Dose De-Escalation of Infliximab in Rheumatoid Arthritis Patients with Stable Low Disease Activity and Treatment
    van der Maas, Aatke
    den Broeder, Alfons
    van den Hoogen, Frank H. J.
    Van Riel, Piet
    van den Bemt, Bart J. F.
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S666 - S666
  • [48] Real World Dose Modification Patterns of Subcutaneous Tocilizumab Among Patients with Rheumatoid Arthritis
    Punekar, Rajeshwari
    Choi, Jeannie
    Boklage, Susan
    Iglesias-Rodriguez, Melitza
    Nola, Kamala
    [J]. AMERICAN HEALTH AND DRUG BENEFITS, 2019, 12 (08): : 400 - 409
  • [49] REDUCTION RATE OF RHEUMATOID FACTOR REFLECTS DISEASE ACTIVITY OF RHEUMATOID ARTHRITIS
    Okumura, N.
    Kawasaki, T.
    Yayama, T.
    Kumagai, K.
    Imai, S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1320 - 1320
  • [50] Utility of Dose Frequency Adjustment in Tocilizumab Administration for Rheumatoid Arthritis
    Saito, Shuntaro
    Kaneko, Yuko
    Izumi, Keisuke
    Takeuchi, Tsutomu
    [J]. JOURNAL OF RHEUMATOLOGY, 2017, 44 (05) : 553 - 557